{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:direct-oral-anticoagulants-doacs",
  "owner": "cardio",
  "kind": "drug",
  "slug": "direct-oral-anticoagulants-doacs",
  "name": "Direct oral anticoagulants (DOACs)",
  "aliases": [
    "Direct oral anticoagulants",
    "Direct-acting oral anticoagulants"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Direct oral anticoagulants are blood thinners taken by mouth. Each of the three US drug labels read for this page names its medicine as one of the direct-acting oral anticoagulants (DOACs). The labels describe two ways of working: two of the medicines block clotting factor Xa, and the third blocks thrombin directly. All three labels list lowering the risk of stroke, and of clots elsewhere in the body, in non-valvular atrial fibrillation among their uses, and all three carry a boxed warning about stopping early. This is the class page: each medicine has its own page.",
  "summary_technical": "Class page. MeSH heading D065427, Factor Xa Inhibitors, is a broad match only: it covers the factor Xa blockers and leaves out the direct thrombin inhibitor. The labels read are those of three products, two factor Xa inhibitors and one direct thrombin inhibitor. The warnings section of each names its product among the direct-acting oral anticoagulants (DOACs); every other statement is scoped to its own product. No trial result and no dose is recorded here.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": "2027-05-09",
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D065427",
      "normalized_value": "D065427",
      "match": "broad",
      "version": "id.nlm.nih.gov linked data, retrieved 2026-11-09",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart",
        "blood-vessels"
      ],
      "condition-area": [
        "arrhythmias",
        "stroke"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "The labels describe selective inhibition of factor Xa for two of the medicines and competitive, direct thrombin inhibition for the third."
  },
  "content_digest": "f161b34ef59a2b548ccd4362ee9dcdc2cf9582248ba275f2a6507d266eecb02d",
  "review": {
    "content_digest": "f161b34ef59a2b548ccd4362ee9dcdc2cf9582248ba275f2a6507d266eecb02d",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "The US label names the direct-acting oral anticoagulants (DOACs) as a group of anticoagulants",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:anticoagulants",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:openfda-label-10db92f9-2300-4a80-836b-673e1ae91610-2026-11-09",
          "locator": "results[0].warnings_and_cautions[0]"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Strategy page for oral anticoagulants in atrial fibrillation",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:oral-anticoagulation",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "A medicine with its own page",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:apixaban",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "A medicine with its own page",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:dabigatran",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "A medicine with its own page",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:edoxaban",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "A medicine with its own page",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:rivaroxaban",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Related condition",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:atrial-fibrillation",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "related_to",
        "label": "Related to",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:post-thrombotic-syndrome",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Related to",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:oral-anticoagulation",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-oral-anticoagulation-prevents-stroke-in-af",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04700826",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04700826-2025-05-16",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/direct-oral-anticoagulants-doacs/",
  "context_path": "api/v1/context/cardio--direct-oral-anticoagulants-doacs.md"
}
